Sign in Subscribe
Epilepsy

Patent Reveals Breakthrough in Treating Epilepsy Patients with Vagus Nerve Stimulation

Strategic Insights

— 1 min read

According to a recent patent filing by Ivan Osorio, a method for treating epilepsy patients using vagus nerve stimulation has been disclosed. The method involves receiving body data streams, analyzing them for cardiac changes, and applying electrical signals to the vagus nerve to treat epileptic seizures. The patent, filed on December 23, 2019, and published on September 30, 2025, reveals a system for treating epilepsy patients using implantable medical devices.

Key Takeaways:

  • The patent describes a method for treating epilepsy patients using vagus nerve stimulation, which involves receiving body data streams, analyzing them for cardiac changes, and applying electrical signals to the vagus nerve to treat epileptic seizures.
  • The system includes at least one electrode coupled to a vagus nerve, a programmable electrical signal generator, a sensor for sensing body data streams, and a logic unit for applying electrical signals to the vagus nerve.
  • The method can sense a kinetic signal and analyze it to determine at least one kinetic index, which can be used to determine the patient's heart rate and whether it is commensurate with the kinetic index.
  • The patent claims include a method of treating a medical condition in a patient using a medical device, which includes a first electrode coupled to a first cranial nerve structure and a second electrode coupled to a second cranial nerve structure.
  • The titration time interval for the electrical signal is based on a patient's age and is a time associated with an adverse effect not recurring in response to an electrical stimulation using an electrical stimulation value.

Statistics:

  • The patent, filed on December 23, 2019, was published on September 30, 2025.
  • The system includes at least one electrode, a programmable electrical signal generator, a sensor, and a logic unit.
  • The ratio of patients treated with the method described in the patent is not specified, but the patent suggests that it can be used to treat patients with epilepsy characterized by cardiac changes.

Sources:

  • Osorio, Ivan. Contingent cardio-protection for epilepsy patients. U.S. Patent Number 12427317, filed December 23, 2019, and published online on September 30, 2025. Patent URL (for desktop use only): https://ppubs.uspto.gov/pubwebapp/external.html?q=(12427317)&db=USPAT&type=ids

Read more